Structures of mesophilic and extremophilic CITRATE (cas 13754-17-1) synthases reveal rigidity and flexibility for function
-
Add time:09/28/2019 Source:infona.pl
CITRATE (cas 13754-17-1) synthase (CS) catalyses the entry of carbon into the citric acid cycle and is highly‐conserved structurally across the tree of life. Crystal structures of dimeric CSs are known in both “open” and “closed” forms, which differ by a substantial domain motion that closes the substrate‐binding clefts. We explore both the static rigidity and the dynamic flexibility of CS structures from mesophilic and extremophilic organisms from all three evolutionary domains. The computational expense of this wide‐ranging exploration is kept to a minimum by the use of rigidity analysis and rapid all‐atom simulations of flexible motion, combining geometric simulation and elastic network modeling. CS structures from thermophiles display increased structural rigidity compared with the mesophilic enzyme. A CS structure from a psychrophile, stabilized by strong ionic interactions, appears to display likewise increased rigidity in conventional rigidity analysis; however, a novel modified analysis, taking into account the weakening of the hydrophobic effect at low temperatures, shows a more appropriate decreased rigidity. These rigidity variations do not, however, affect the character of the flexible dynamics, which are well conserved across all the structures studied. Simulation trajectories not only duplicate the crystallographically observed symmetric open‐to‐closed transitions, but also identify motions describing a previously unidentified antisymmetric functional motion. This antisymmetric motion would not be directly observed in crystallography but is revealed as an intrinsic property of the CS structure by modeling of flexible motion. This suggests that the functional motion closing the binding clefts in CS may be independent rather than symmetric and cooperative. Proteins 2014; 82:2657–2670. © 2014 Wiley Periodicals, Inc.
We also recommend Trading Suppliers and Manufacturers of CITRATE (cas 13754-17-1). Pls Click Website Link as below: cas 13754-17-1 suppliers
Prev:Combined pioglitazone–metformin and clomiphene CITRATE (cas 13754-17-1) versus metformin and clomiphene CITRATE (cas 13754-17-1) in induction of ovulation in women with clomiphene CITRATE (cas 13754-17-1)-resistant polycystic ovary syndrome
Next:Effect of trisodium CITRATE (cas 13754-17-1) on electrolytic deposition of hydroxyapatite coatings) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Tributyl CITRATE (cas 13754-17-1) as an effective plasticizer for biodegradable polymers: effect of plasticizer on free volume and transport and mechanical properties09/30/2019
- Effect of trisodium CITRATE (cas 13754-17-1) on electrolytic deposition of hydroxyapatite coatings09/29/2019
- Combined pioglitazone–metformin and clomiphene CITRATE (cas 13754-17-1) versus metformin and clomiphene CITRATE (cas 13754-17-1) in induction of ovulation in women with clomiphene CITRATE (cas 13754-17-1)-resistant polycystic ovary syndrome10/01/2019
- Effects of mosapride CITRATE (cas 13754-17-1), metoclopramide hydrochloride, lidocaine hydrochloride, and cisapride CITRATE (cas 13754-17-1) on equine gastric emptying, small intestinal and caecal motility09/27/2019
- A randomized controlled trial of the efficacy of rosiglitazone and clomiphene CITRATE (cas 13754-17-1) versus metformin and clomiphene CITRATE (cas 13754-17-1) in women with clomiphene CITRATE (cas 13754-17-1)–resistant polycystic ovary syndrome09/26/2019
- Observational Study of Need for Thrombolytic Therapy and Incidence of Bacteremia using Taurolidine‐CITRATE (cas 13754-17-1)‐Heparin, Taurolidine‐CITRATE (cas 13754-17-1) and Heparin Catheter Locks in Patients Treated with Hemodialysis09/25/2019